Inj.
Renamic Vet
Generic Drug: Tranexamic Acid
View Alternative Brand Names (2)Drug Class: Antihemorrhagics
Manufacturer: Renata Pharmaceuticals Ltd.
Basic information
Presentation and price
10 ml vial
30 ml vial
Dose and dosage
1ml/4-20kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/4-20kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/7-10kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/7-10kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/7-10kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/10kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/10kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
1ml/4-20kg body weight once/twice a day. If necessary repeat every 8 hours.
For external use: Should be applied with cotton as required.
- Surgical Bleeding
- Accidental Bleeding
- Nasal Bleeding
- Rectal Bleeding
- Uterine Bleeding
- Bleeding during or before parturition
- Hematuria
- Bleeding due different disease conditions
Tranexamic acid can be used in any hemorrhagic condition of animals
N/A
N/A
Tranexamic acid competitively and reversibly inhibits the activation of plasminogen via binding at several distinct sites, including four or five low-affinity sites and one high-affinity site, the latter of which is involved in its binding to fibrin. The binding of plasminogen to fibrin induces fibrinolysis - by occupying the necessary binding sites tranexamic acid prevents this dissolution of fibrin, thereby stabilizing the clot and preventing hemorrhage.
Albutrepenonacog alfa : Tranexamic acid may increase the thrombogenic activities of Albutrepenonacog alfa.
Alpha-1-proteinase inhibitor : Alpha-1-proteinase inhibitor may increase the thrombogenic activities of Tranexamic acid.
Alteplase : The therapeutic efficacy of Tranexamic acid can be decreased when used in combination with Alteplase.
Aminocaproic acid: Tranexamic acid may increase the thrombogenic activities of Aminocaproic acid.
Andexanet alfa: Tranexamic acid may increase the thrombogenic activities of Andexanet alfa
Meat: 2days.
Milk: 2 days